{
  "DOI": "10.1007/s12687-022-00608-w",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-022-00608-w",
  "alternative-id": [
    "608"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "24 September 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Sarah Wordsworth and James Buchanan are co-applicants of a project funded through Genome British Columbia’s Genesolve programme and Illumina, and have received travel support from Illumina to attend conferences in Baltimore (USA), Barcelona (Spain), and Basel (Switzerland). Ilias Goranitis, Ingrid Slade, Angeliki Kerasidou, Mark Sheehan, and Katerina Sideri have no conflicts of interest to declare."
    },
    {
      "label": "Free to read",
      "name": "free",
      "value": "This content has been made available to all."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Buchanan",
      "given": "J.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Goranitis",
      "given": "I.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Slade",
      "given": "I.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kerasidou",
      "given": "A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sheehan",
      "given": "M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sideri",
      "given": "K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wordsworth",
      "given": "S.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        9,
        24
      ]
    ],
    "date-time": "2022-09-24T05:02:46Z",
    "timestamp": 1663995766000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        10,
        3
      ]
    ],
    "date-time": "2022-10-03T20:12:28Z",
    "timestamp": 1664827948000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        10,
        4
      ]
    ],
    "date-time": "2022-10-04T04:44:35Z",
    "timestamp": 1664858675930
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2022,
        9,
        24
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2022,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            9,
            24
          ]
        ],
        "date-time": "2022-09-24T00:00:00Z",
        "timestamp": 1663977600000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            9,
            24
          ]
        ],
        "date-time": "2022-09-24T00:00:00Z",
        "timestamp": 1663977600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-022-00608-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s12687-022-00608-w/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-022-00608-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "463-466",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2022,
        9,
        24
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        9,
        24
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s12687-021-00541-4",
      "doi-asserted-by": "publisher",
      "key": "608_CR1",
      "unstructured": "Abbott M, McKenzie L, Moran BVG, Heidenreich S, Hernandez R et al. (2021) Continuing the sequence? Towards an economic evaluation of whole genome sequencing for the diagnosis of rare diseases in Scotland. J Community Genet. https://doi.org/10.1007/s12687-021-00541-4"
    },
    {
      "DOI": "10.1177/0272989X19866415",
      "author": "L Abel",
      "doi-asserted-by": "publisher",
      "first-page": "857",
      "issue": "7",
      "journal-title": "Med Decis Making",
      "key": "608_CR2",
      "unstructured": "Abel L, Shinkins B, Smith A, Sutton AJ, Sagoo GS et al (2019) Early economic evaluation of diagnostic technologies: experiences of the NIHR diagnostic evidence co-operatives. Med Decis Making 39(7):857–866. https://doi.org/10.1177/0272989X19866415",
      "volume": "39",
      "year": "2019"
    },
    {
      "DOI": "10.1017/S0266462322000484",
      "author": "J Bouttell",
      "doi-asserted-by": "publisher",
      "first-page": "e67",
      "issue": "1",
      "journal-title": "Int J Technol Assess Health Care",
      "key": "608_CR3",
      "unstructured": "Bouttell J, Heggie R, Oien K, Romaniuk A, VanSteenhouse H et al (2022) Economic evaluation of genomic/genetic tests: a review and future directions. Int J Technol Assess Health Care 38(1):e67. https://doi.org/10.1017/S0266462322000484",
      "volume": "38",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41431-019-0452-z",
      "author": "J Buchanan",
      "doi-asserted-by": "publisher",
      "first-page": "1639",
      "issue": "11",
      "journal-title": "Eur J Hum Genet",
      "key": "608_CR4",
      "unstructured": "Buchanan J, Blair E, Thomson KL, Ormondroyd E, Watkins H et al (2019) Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease. Eur J Hum Genet 27(11):1639–1648. https://doi.org/10.1038/s41431-019-0452-z",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41397-022-00277-5",
      "author": "V Diaby",
      "doi-asserted-by": "publisher",
      "first-page": "223",
      "issue": "4",
      "journal-title": "Pharmacogenomics J",
      "key": "608_CR5",
      "unstructured": "Diaby V, Babcock A, Huang Y, Moussa RK, Espinal PS et al (2022) Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States. Pharmacogenomics J 22(4):223–229. https://doi.org/10.1038/s41397-022-00277-5",
      "volume": "22",
      "year": "2022"
    },
    {
      "key": "608_CR6",
      "unstructured": "Genome British Columbia. Quantifying the value of genomics-driven healthcare for children with rare diseases: a multi-country economic analysis. 2019 15/08/22]; Available from: https://www.genomebc.ca/projects/quantifying-the-value-of-genomics-driven-healthcare-for-children-with-rare-diseases-a-multi-country-economic-analysis."
    },
    {
      "DOI": "10.1038/s41431-021-00874-1",
      "author": "I Goranitis",
      "doi-asserted-by": "publisher",
      "first-page": "1645",
      "journal-title": "Eur J Hum Genet",
      "key": "608_CR7",
      "unstructured": "Goranitis I, Best S, Christodoulou J, Boughtwood T, Stark Z (2021) Preferences and values for rapid genomic testing in critically ill infants and children: a discrete choice experiment. Eur J Hum Genet 29:1645–1653. https://doi.org/10.1038/s41431-021-00874-1",
      "volume": "29",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.gim.2022.01.013",
      "author": "I Goranitis",
      "doi-asserted-by": "publisher",
      "first-page": "1037",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "608_CR8",
      "unstructured": "Goranitis I, Wu Y, Lunke S, White SM, Tan TY et al (2022) Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children. Genet Med 24(5):1037–1044. https://doi.org/10.1016/j.gim.2022.01.013",
      "volume": "24",
      "year": "2022"
    },
    {
      "key": "608_CR9",
      "unstructured": "IQVIA (2020) Understanding the global landscape of genomic initiatives: progress and promise. https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/understanding-the-global-landscape-of-genomicsinitiatives.pdf"
    },
    {
      "DOI": "10.1007/s12687-020-00503-2",
      "doi-asserted-by": "publisher",
      "key": "608_CR10",
      "unstructured": "Lejeune C, Amado IF (2021) Valuing genetic and genomic testing in France: current challenges and latest evidence. J Community Genet.https://doi.org/10.1007/s12687-020-00503-2"
    },
    {
      "DOI": "10.1007/s12687-021-00517-4",
      "doi-asserted-by": "publisher",
      "key": "608_CR11",
      "unstructured": "Munthe C (2021) The ethics of resource allocation in translational genomic medicine. J Community Genet. https://doi.org/10.1007/s12687-021-00517-4"
    },
    {
      "DOI": "10.1007/s12687-021-00551-2",
      "doi-asserted-by": "publisher",
      "key": "608_CR12",
      "unstructured": "Norris S, Belcher A, Howard K, Ward RL (2021) Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessments. J Community Genet. https://doi.org/10.1007/s12687-021-00551-2"
    },
    {
      "DOI": "10.1136/bmjgh-2020-004415",
      "doi-asserted-by": "publisher",
      "key": "608_CR13",
      "unstructured": "Phillips KA, Douglas MP, Wordsworth S, Buchanan J, Marshall DA (2021) Availability and funding of clinical genomic sequencing globally. BMJ Glob Health 6(2). https://doi.org/10.1136/bmjgh-2020-004415"
    },
    {
      "DOI": "10.1038/gim.2017.247",
      "author": "K Schwarze",
      "doi-asserted-by": "publisher",
      "first-page": "1122",
      "issue": "10",
      "journal-title": "Genet Med",
      "key": "608_CR14",
      "unstructured": "Schwarze K, Buchanan J, Taylor JC, Wordsworth S (2018) Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med 20(10):1122–1130. https://doi.org/10.1038/gim.2017.247",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s40273-021-01073-y",
      "author": "MJHG Simons",
      "doi-asserted-by": "publisher",
      "first-page": "1429",
      "journal-title": "C/IV Non-squamous Non-small-Cell Lung Cancer. PharmacoEconomics",
      "key": "608_CR15",
      "unstructured": "Simons MJHG, Retèl VP, Ramaekers BLT et al (2021) Early cost effectiveness of Whole-Genome sequencing as a clinical diagnostic test for patients with inoperable stage IIIB. C/IV Non-squamous Non-small-Cell Lung Cancer. Pharmaco Economics 39:1429–1442. https://doi.org/10.1007/s40273-021-01073-y",
      "volume": "39",
      "year": "2021"
    },
    {
      "DOI": "10.1056/NEJMoa2035790",
      "author": "D Smedley",
      "doi-asserted-by": "publisher",
      "first-page": "1868",
      "issue": "20",
      "journal-title": "N Engl J Med",
      "key": "608_CR16",
      "unstructured": "Smedley D, Smith KR, Martin A, Thomas EA, McDonagh EM et al (2021) 100,000 genomes pilot on rare-disease diagnosis in health care — preliminary report. N Engl J Med 385(20):1868–1880. https://doi.org/10.1056/NEJMoa2035790",
      "volume": "385",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s12920-017-0273-2",
      "author": "NR Sperber",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "issue": "1",
      "journal-title": "BMC Med Genomics",
      "key": "608_CR17",
      "unstructured": "Sperber NR, Carpenter JS, Cavallari LH, Damschroder LJ, Cooper-DeHoff RM et al (2017) Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network. BMC Med Genomics 10(1):35. https://doi.org/10.1186/s12920-017-0273-2",
      "volume": "10",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s40273-022-01181-3",
      "doi-asserted-by": "publisher",
      "key": "608_CR18",
      "unstructured": "Tafazzoli A, Ramsey SD, Shaul A, Chavan A, Ye W et al (2022) The potential value-based price of a multi-cancer early detection genomic blood test to complement current single cancer screening in the USA. Pharmacoeconomics. https://doi.org/10.1007/s40273-022-01181-3"
    },
    {
      "key": "608_CR19",
      "unstructured": "The Centre for Personalised Medicine. Resource allocation in personalised medicine: evaluation, translation \u0026 ethics. 2018 15/08/22]; Available from: https://cpm.well.ox.ac.uk/event/resource-allocation-personalised-medicine-evaluation-translation-ethics-0."
    },
    {
      "DOI": "10.2217/pgs-2020-0091",
      "author": "RM Turner",
      "doi-asserted-by": "publisher",
      "first-page": "1237",
      "issue": "17",
      "journal-title": "Pharmacogenomics",
      "key": "608_CR20",
      "unstructured": "Turner RM, Newman WG, Bramon E, McNamee CJ, Wong WL et al (2020) Pharmacogenomics in the UK National Health Service: opportunities and challenges. Pharmacogenomics 21(17):1237–1246. https://doi.org/10.2217/pgs-2020-0091",
      "volume": "21",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s12687-019-00428-5",
      "doi-asserted-by": "publisher",
      "key": "608_CR21",
      "unstructured": "Weymann D, Dragojlovic N, Pollard S, Regier DA (2019) Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges. J Community Genet. https://doi.org/10.1007/s12687-019-00428-5"
    },
    {
      "DOI": "10.1007/s12687-021-00557-w",
      "doi-asserted-by": "publisher",
      "key": "608_CR22",
      "unstructured": "Weymann D, Laskin J, Jones SJM, Roscoe R, Lim HJ et al (2021) Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care. J Community Genet. https://doi.org/10.1007/s12687-021-00557-w"
    },
    {
      "DOI": "10.1038/d41586-021-00313-7",
      "author": "A Wonkam",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "issue": "7845",
      "journal-title": "Nature",
      "key": "608_CR23",
      "unstructured": "Wonkam A (2021) Sequence three million genomes across Africa. Nature 590(7845):209–211. https://doi.org/10.1038/d41586-021-00313-7",
      "volume": "590",
      "year": "2021"
    }
  ],
  "reference-count": 23,
  "references-count": 23,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s12687-022-00608-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Resource allocation in genetic and genomic medicine"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}